Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tobacco Induced Diseases
Published in: Tobacco Induced Diseases 1/2016

Open Access 01-12-2016 | Reviewer acknowledgement

Acknowledgement of manuscript reviewers 2015

Authors: James Elliott Scott, Constantine Vardavas

Published in: Tobacco Induced Diseases | Issue 1/2016

Login to get access

Contributing reviewers

The editors of Tobacco Induced Diseases would like to thank all our reviewers who have contributed to the journal in Volume 13 (2015).
Metadata
Title
Acknowledgement of manuscript reviewers 2015
Authors
James Elliott Scott
Constantine Vardavas
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2016
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-016-0071-1

Other articles of this Issue 1/2016

Tobacco Induced Diseases 1/2016 Go to the issue

Research

Effectiveness of advice from physician and nurse on smoking cessation stage in Taiwanese male smokers attending a community-based integrated screening program

Research

Prevalence and correlates of tobacco use among adolescents in the schools of Kalaiya, Nepal: a cross-sectional questionnaire based study

Research

Relationship between salivary stress biomarker levels and cigarette smoking in healthy young adults: an exploratory analysis

Research

The opinions of adults about the ban on cigarette sales to minors

Review

A gaping gap (smokeless tobacco control in Pakistan)

Short report

Educating smokers about the risk of blindness – insights to improve tobacco product health warning labels
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits